Stryker showcases continued innovation across orthopaedics at AAOS 2026 Annual Meeting
MWN-AI** Summary
At the American Academy of Orthopaedic Surgeons' (AAOS) 2026 Annual Meeting in New Orleans, Stryker, a global leader in medical technology, highlighted its ongoing commitment to innovation in the orthopaedic sector. The company unveiled a series of advancements, including the latest iterations of its Triathlon® Total Knee System, an expanded Mako SmartRobotics™ portfolio, and new offerings in power tools.
Central to the showcase was the Triathlon Gold, Stryker's first commercially available femoral component designed for patients with metal sensitivity. Utilizing additive manufacturing, this component features a Titanium nitride surface and cementless technology aimed at enhancing long-term durability and scratch resistance. Additionally, Stryker presented the Triathlon Medial Stabilized (MS) Insert, which harmonizes Mako SmartRobotics™ with cementless technologies to improve stability and promote natural movement for patients undergoing primary knee procedures.
Another significant debut was the Mako Shoulder, now fully released to the market, intended to simplify primary reverse shoulder surgeries and enhance surgical precision through integrated planning software and advanced robotics. Stryker also introduced the Mako RPS, a handheld robotic power system compatible with the Triathlon Total Knee System, catering to surgeons who prefer manual power tool familiarity while benefiting from robotic assistance.
Complementing these innovations, the company unveiled the BPX™ cordless micro power tool system for extremity procedures and the TPX® HD tool, designed specifically for total joint revisions and minimally invasive surgeries. The new 7900 Attachments were also showcased as part of the next generation of surgical tools.
With these advancements, Stryker continues to set a high standard in orthopaedic care, emphasizing solutions shaped by customer insights to address the evolving needs of patients and surgeons alike. Attendees were encouraged to visit Stryker's booth for demonstrations and further information on these innovative products.
MWN-AI** Analysis
Stryker Corporation (NYSE: SYK) has recently solidified its position as a leader in orthopedic innovation at the AAOS 2026 Annual Meeting, unveiling cutting-edge advancements that signify a strategic response to evolving market needs. With the introduction of products like the Triathlon Gold femoral component and the Mako robotic surgical system expansions, Stryker is not just enhancing its product lineup; it’s also leading a paradigm shift in orthopedic surgery.
The Triathlon Gold's use of 3D printing technology to produce a component suited for patients with metal sensitivities represents a proactive approach to patient demographics increasingly concerned about biocompatibility in implants. This innovation, combined with improved stability features like the Triathlon Medial Stabilized Insert, positions Stryker to capture a growing segment of the market craving personalized orthopedic solutions.
The full-scale market release of the Mako Shoulder system is another strategic move, as it integrates advanced technology to assist surgeons in complex procedures. This reflects a broader trend in healthcare towards precision surgery, which is not only attractive to orthopedic surgeons but also increasingly appealing to patients.
Additionally, with enhancements in the power tool portfolio, including the BPX cordless micro system and TPX HD tools, Stryker is addressing the practical needs of surgeons, thereby enhancing surgical efficiency and outcomes.
Given Stryker's robust commitment to innovation and its strategic enhancements aimed at addressing both surgeon and patient needs, this could be an opportune time for investors to consider Stryker stock. The combination of ongoing technological advancements and a strong reputation positions Stryker favorably in the competitive orthopedic market. As the industry evolves, Stryker is likely to continue leading with innovative solutions that promise both patient satisfaction and financial growth potential.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
PR Newswire
Evolving technologies and offerings reinforce commitment to shaping the future of orthopaedic care
PORTAGE, Mich., March 3, 2026 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, showcases its commitment to innovation across orthopaedic specialties with the introduction of the newest additions to the Triathlon® Total Knee System, the expanded Mako SmartRobotics™ portfolio and continued evolution of the power tool portfolio at the American Academy of Orthopaedic Surgeons' (AAOS) 2026 Annual Meeting in New Orleans.
Triathlon Gold: Building on the legacy and trusted performance1 of the Triathlon system, Triathlon Gold is Stryker's first commercially available femoral component, designed as an option for patients with metal sensitivity concerns. Using additive manufacturing, also known as 3D printing, it features a Titanium nitride surface and Triathlon cementless technology designed to deliver fixation2 and long-term durability3 with scratch resistance superior to competitive surfaces4, and the flexibility for both cemented and cementless workflows.
Triathlon Medial Stabilized (MS) Insert: Another advancement in the Triathlon Total Knee System, the MS Insert allows customers to leverage the advantages of Mako SmartRobotics™ and Triathlon Cementless technologies, now with your preferred tibial insert. The MS Insert is designed to provide enhanced stability5-7 for Triathlon primary knee patients, while allowing more natural rotational kinematics.8
"With more than 20 years of proven outcomes, the Triathlon system has set a high standard in knee replacement," said Lisa Kloes, vice president and general manager of Stryker's Knee business. "Triathlon Gold and the Triathlon Medial Stabilized (MS) Insert represent the next evolution of that legacy -- solutions shaped by customer insight and designed to meet the evolving needs of patients."
Mako Shoulder: Now in full market release, Mako Shoulder is designed to transform primary reverse shoulder surgery by simplifying complex clinical tasks, giving surgeons confidence in executing their procedure to plan. The platform integrates Tornier Perform Reversed shoulder implants, Blueprint planning software and Mako SmartRobotics™ to deliver a comprehensive, connected solution. Mako Shoulder will also be available on Mako 4 in the second half of 2026.
Mako RPS: Previously announced, the newest addition to join the Mako family is Mako RPS (Robotic Power System) for Total Knee. Compatible with Stryker's Triathlon Total Knee System, Mako RPS is a handheld robotic system that combines Stryker's proven robotics and power tool legacies and represents Mako's solution for a subset of surgeons looking for the familiarity of a manual power tool while leveraging the advantages of enabling technology.
BPX™ and TPX® HD: New introductions to the power tools portfolio include the?BPX?cordless micro power tool?system for extremities procedures?and?TPX HD, a comprehensive solution built for the needs of total joint revisions, trauma and minimally invasive foot and ankle surgeries with enhanced power,?customizable?control, and?specialized attachments capable of cutting through metal and bone cement.?These launches are complemented by?the?7900 Attachments,?the?next generation of surgical attachments,?representing?an advancement in attachment design.
"As the industry continues to evolve, Stryker is expanding our capabilities across orthopaedic specialties," said Katherine Truppi, president of Stryker's Joint Replacement division. "Surgeons and patients are seeking more solutions, and these innovations are designed to do just that -- helping patients get back to the activities they love."
Attendees of the AAOS 2026 Annual Meeting can visit Stryker's booth (#3339) to learn more about these products, among others. Stryker will hold demonstrations, exhibitions and several symposiums throughout the week.
About Stryker
Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.
Media contact
Stryker, Joint Replacement
Niamh Grano
Sr. Communications Manager
niamh.grano@stryker.com
References
- Nam, D., Lawrie, C. M., Salih, R., Nahhas, C. R., Barrack, R. L., & Nunley, R. M. (2019). Cemented Versus Cementless Total Knee Arthroplasty of the Same Modern Design. The Journal of Bone and Joint Survery, 101(13), 1185-1192. doi:10.2106/jbjs.18.01162
- Stryker Test Report: D0000325745 Triathlon Gold Micromotion Verification Testing. July, 2025.
- Stryker Test Report: D0000321183. Triathlon Gold CR Femoral Component: Posterior Femoral Fatigue Verification Testing. September, 2025.
- Stryker Test Report: D0000394012. Comparative Evaluation of Scratch Resistance in Total Knee Femoral Implants: Triathlon Gold (TiN-coated Ti6AL4V) vs. Oxinium Legion (Oxidized Zr-2.5Nb). September, 2025.
- D0000373518. Virtual Range of Constraint Measurement of Triathlon Medial Stabilized Insert Family in Extension.
- D0000361177. Virtual Range of Constraint Measurement of Triathlon Medial Stabilized Insert Family in Active Flexion.
- D0000373525. Virtual Range of Constraint Measurement of Triathlon Medial Stabilized Insert Family in Deep Flexion.
- D0000367859. Knee Kinematic Model (KKM) Library Verification of the Medial Stabilized Insert
JR-GSNPS-PRESS-3062400
SOURCE Stryker
FAQ**
How does the introduction of Triathlon Gold and the Triathlon Medial Stabilized Insert reflect Stryker Corporation SYK's commitment to addressing patient needs and enhancing surgical outcomes in orthopaedics?
In what ways do the advancements in Stryker Corporation SYK's Mako SmartRobotics™ portfolio aim to improve the efficiency and effectiveness of primary reverse shoulder surgeries?
Can you elaborate on the strategic importance of integrating the BPX™ and TPX® HD tools within Stryker Corporation SYK's existing power tools portfolio for joint revisions and trauma surgeries?
How does Stryker Corporation SYK plan to utilize customer insights and market feedback to drive the future innovations showcased at the AAOS 2026 Annual Meeting?
**MWN-AI FAQ is based on asking OpenAI questions about Stryker Corporation (NYSE: SYK).
NASDAQ: SYK
SYK Trading
-2.2% G/L:
$363.80 Last:
696,996 Volume:
$366.57 Open:
